Log In Sign Up

Trading

Trading

Browse Companies

Data

Data

IPO Stock Tracker

Solutions

Solutions

For Institutions

For Shareholders

Insights

Insights

Popular Topics

Buying Pre-IPO Shares

Selling Pre-IPO Shares

Private Market Reports

Private Market Data & Analytics

About

About

Investor Relations

People & Culture

Adicet Bio Stock

adicetbio.comHealthcareFounded: 1900Funding to Date: $131MM

Adicet Bio is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases.

Learn more about Adicet Bio IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Adicet Bio.

Register Today

Team

Management Team

Carrie Krehlik

Chief Human Resources Officer

Francesco Galimi MD

Chief Medical Officer & Senior Vice President

Brian Hogan

Chief Financial Officer

Aya Jakobovits Ph.D

Founder, Board Member & Senior Advisor

Anil Singhal Ph.D

Chief Executive Officer, President & Board Member

Stewart Abbot Ph.D

Chief Scientific Officer & Chief Operating Officer

Donald Santel

Chairman

Board Members

Asish Xavier Ph.D

Johnson & Johnson Innovation - JJDC

Erez Chimovits

OrbiMed

Michal Silverberg

Novartis Venture Fund

Carl Gordon

Donald Santel

Jonathan Silverstein

Aya Jakobovits Ph.D

Florent Gros

Novartis Venture Fund

Yair Schindel MD

aMoon Fund

Other companies like Adicet Bio in the Healthcare sector

Sector

Last Round Est. Valuation

$2.15B

Colossal Biosciences

Sector

Sector

Last Round Est. Valuation

$3.67B

Sector

Last Round Est. Valuation

$400.53MM

Sector

Last Round Est. Valuation

$4.26B

Sector

Mammoth Biosciences

Sector

Last Round Est. Valuation

$1.08B

Sector

Precision Neuroscience

Sector

News

Globes 10/03/2019

aMoon invests in $80m Adicet Bio financing round

Frequently Asked Questions